Progress Report – ACCURATE Study – February 2023

ACCURATE Study (UroCCR No. 99)

With 12,000 new cases diagnosed annually in France, kidney cancer ranks as the third most common urological tumour in adults. In recent years, minimally invasive kidney-sparing surgery using robotic assistance has become the preferred treatment approach.

The ACCURATE study aims to further improve the quality of surgical procedures by guiding the surgeon with advanced 3D modelling.

A total of 10 patients have been included since the study began last month.

Many thanks to the participating centres for these inclusions!